No abstract available
MeSH terms
-
Abnormalities, Drug-Induced / etiology
-
Adolescent
-
Adult
-
Angiogenesis Inhibitors / pharmacology
-
Angiogenesis Inhibitors / therapeutic use*
-
Animals
-
Anti-HIV Agents / pharmacology
-
Anti-HIV Agents / therapeutic use*
-
Antineoplastic Agents / pharmacology
-
Antineoplastic Agents / therapeutic use*
-
Autoimmune Diseases / drug therapy
-
Contraindications
-
Dermatologic Agents / pharmacology
-
Dermatologic Agents / therapeutic use*
-
Erythema Nodosum / drug therapy
-
Female
-
Graft vs Host Disease / drug therapy
-
HIV Infections / drug therapy
-
Hematologic Diseases / drug therapy
-
Humans
-
Immunosuppressive Agents / pharmacology
-
Immunosuppressive Agents / therapeutic use*
-
Infant, Newborn
-
Leprostatic Agents / pharmacology
-
Leprostatic Agents / therapeutic use*
-
Male
-
Multiple Myeloma / drug therapy
-
Neoplasms / drug therapy
-
Pregnancy
-
Rabbits
-
Rats
-
Skin Diseases / drug therapy
-
Thalidomide / administration & dosage
-
Thalidomide / adverse effects
-
Thalidomide / pharmacology
-
Thalidomide / therapeutic use*
-
Time Factors
Substances
-
Angiogenesis Inhibitors
-
Anti-HIV Agents
-
Antineoplastic Agents
-
Dermatologic Agents
-
Immunosuppressive Agents
-
Leprostatic Agents
-
Thalidomide